Laura Fariselli | Searcharxiv

arXiv2026

A Scalable AI-Powered System for Explainable Machine Learning Pipelines in Brain Tumor

Artificial intelligence and radiomics are increasingly used in brain tumor research, yet their translation into clinical practice remains limited by fragmented workflows, poor transparency, and weak integration with end users' needs. We present the first version of a scalable web-based visual analytics system designed to support radiomics-driven machine learning inference in neuro-oncology. The platform integrates three core functions within a single interface: cohort management from structured clinical tables, radiomic feature extraction from medical images and segmentation masks, and guarded inference with pre-trained machine learning models. The system was developed through an iterative user-centred design process and evaluated on both a public glioblastoma dataset and a proprietary clinical cohort. A key contribution is the explicit exposure of intermediate workflow artifacts, which improves traceability, interpretability, and responsible use of AI. By combining portability, inspectability, and deployment simplicity, the proposed framework offers a practical foundation for clinically oriented AI applications in brain tumor analysis.

cs.SE↗

arXiv2026

Radiomics- and Clinical Feature-Driven Prediction of Volumetric Response in Skull-Base Meningioma after CyberKnife Radiosurgery

Skull-base meningiomas are often characterized by favorable long-term prognosis, yet their anatomical complexity and proximity to critical neurovascular structures make treatment selection challenging. Stereotactic radiosurgery with CyberKnife represents an effective therapeutic option when surgical resection is not feasible; however, not all patients benefit equally from this treatment. Early identification of patients likely to respond to radiosurgery remains an open clinical problem. In this study, we propose a radiomics- and clinical feature-driven framework for predicting volumetric response in skull-base meningiomas treated with CyberKnife. Unlike most existing approaches that focus on progression-free survival or recurrence, our method targets volumetric response as an indicator of treatment efficacy. Pre-treatment MRI images from 104 patients were processed to extract radiomic features, which were combined with clinical variables and analyzed using six models. To ensure methodological rigor, the entire modeling process was implemented within a nested cross-validation scheme. Among the evaluated models, TabPFN achieved the best overall performance, with an AUC of 0.81 and consistently favorable classification metrics. These results suggest that advanced machine learning architectures, when combined with robust validation strategies, can effectively capture patterns associated with treatment response even in small-sample, high-dimensional settings.

cs.CV↗